PMID- 21348313 OWN - NLM STAT- MEDLINE DCOM- 20120919 LR - 20181201 IS - 0513-4870 (Print) IS - 0513-4870 (Linking) VI - 45 IP - 10 DP - 2010 Oct TI - [Oral cavity delivery system of unfractionated and low molecular weight heparin]. PG - 1317-21 AB - The difference between absorption of unfractionated heparin (UFH) and low molecular weight heparin (LMWH) after oral and oral cavity administration were studied respectively, and the compatible enhancer for oral cavity delivery system of both drugs was found. The LMWH and UFH films were prepared with two bioadhesive materials Carbopol and alginate sodium for oral cavity delivery. The activated partial thromboplastin time (APTT) was used to determine LMWH and UFH in plasma after oral, oral cavity and sc administration in rats. The results show that the enhancer (Labrasol) can increase the absorption of LMWH and UFH through oral cavity in rats but not obviously. The oral cavity iontophoretic delivery system is a useful method to improve the absorption of LMWH and UFH through oral cavity mucosa. FAU - Li, Ding AU - Li D AD - National Pharmaceutical Engineering & Research Center Shanghai 201203, China. FAU - Hou, Hui-min AU - Hou HM LA - chi PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - China TA - Yao Xue Xue Bao JT - Yao xue xue bao = Acta pharmaceutica Sinica JID - 21710340R RN - 0 (Acrylic Resins) RN - 0 (Alginates) RN - 0 (Anticoagulants) RN - 0 (Drug Carriers) RN - 0 (Glycerides) RN - 0 (Heparin, Low-Molecular-Weight) RN - 0 (Hexuronic Acids) RN - 0 (Organic Chemicals) RN - 0 (Polyvinyls) RN - 00BT03FSO2 (Labrasol) RN - 0A5MM307FC (carboxypolymethylene) RN - 8A5D83Q4RW (Glucuronic Acid) RN - 9005-49-6 (Heparin) SB - IM MH - Absorption MH - Acrylic Resins MH - Administration, Oral MH - Alginates/chemistry MH - Animals MH - Anticoagulants/administration & dosage/pharmacokinetics MH - Drug Carriers MH - Drug Delivery Systems MH - Glucuronic Acid/chemistry MH - Glycerides MH - Heparin/*administration & dosage/*pharmacokinetics MH - Heparin, Low-Molecular-Weight/*administration & dosage/*pharmacokinetics MH - Hexuronic Acids/chemistry MH - Injections, Intradermal MH - Iontophoresis MH - Male MH - Mouth MH - Organic Chemicals/pharmacology MH - Partial Thromboplastin Time MH - Polyvinyls/chemistry MH - Rats MH - Rats, Sprague-Dawley EDAT- 2011/02/26 06:00 MHDA- 2012/09/20 06:00 CRDT- 2011/02/26 06:00 PHST- 2011/02/26 06:00 [entrez] PHST- 2011/02/26 06:00 [pubmed] PHST- 2012/09/20 06:00 [medline] PST - ppublish SO - Yao Xue Xue Bao. 2010 Oct;45(10):1317-21.